← Back to Search

5mm retraction of clip deployment apparatus. for Breast Biopsy

N/A
Waitlist Available
Led By Stefanie Woodard, MD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through 1 hour (post biopsy mammogram/procedure)
Awards & highlights

Study Summary

This trial will enroll 250 female patients who are already scheduled for a stereotactic biopsy. They will be randomly assigned to one of two groups, one of which will have a 5 mm retraction of the biopsy clip post-placement. There is no intervention that is not already part of standard care. The trial will last approximately six months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through 1 hour (post biopsy mammogram/procedure)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through 1 hour (post biopsy mammogram/procedure) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average Distance of Clip Migration for the Arm That Did Not Receive Clip Retraction.
Average Distance of Clip Migration for the Arm That Received 5mm Retraction.
Number of Breast Biopsy Patients Whose Clip Migrated Greater Than 10mm From the Biopsy Site.
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 5mm retraction of clip deployment apparatusExperimental Treatment1 Intervention
The participants in this group will have clip placement 5mm in front of the biopsy site site.
Group II: no retraction of clip deployment apparatusActive Control1 Intervention
These participants will the clip delivered at the biopsy site.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
5mm retraction of clip deployment apparatus.
2020
N/A
~250

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,279,799 Total Patients Enrolled
Stefanie Woodard, MDPrincipal InvestigatorUniversity of Alabama at Birmingham
1 Previous Clinical Trials
20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research encompass those who are over four decades old?

"According to the established parameters for this trial, the minimum age of admission is 18 while those aged 99 and below are eligible."

Answered by AI

Would I meet the criteria for admission to this experiment?

"Those who wish to participate in the research must be between 18 and 99 years of age, with biopsy results that meet pre-specified criteria. This trial is set to admit a total of 250 individuals in total."

Answered by AI

How many participants are involved in this experiment?

"That is accurate. According to clinicaltrials.gov, the trial which was first announced on August 3rd 2020 has recently been looking for 250 individuals from a single site."

Answered by AI

Are there any open opportunities to join this research endeavor?

"Indeed, clinicaltrials.gov affirms that this medical trial is presently recruiting members. It was first advertised on August 3rd 2020 and the listing has been updated most recently on August 24th 2022. 250 individuals need to be enrolled at a single site for participation in the study."

Answered by AI
~52 spots leftby Apr 2025